FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

37911311000001102: Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Dec 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1148651000001113 Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1148661000001111 Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) Has excipient Sorbic acid false Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) Is a Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) Has specific active ingredient Erythromycin stearate true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has AMP True Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start